1. Home
  2. PASW vs QNCX Comparison

PASW vs QNCX Comparison

Compare PASW & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PASW

Ping An Biomedical Co. Ltd. Ordinary Shares

N/A

Current Price

$0.15

Market Cap

20.4M

ML Signal

N/A

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$1.08

Market Cap

19.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PASW
QNCX
Founded
2021
2012
Country
Hong Kong
United States
Employees
7
N/A
Industry
Apparel
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
19.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PASW
QNCX
Price
$0.15
$1.08
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
140.8K
1.5M
Earning Date
05-11-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.88
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.34
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.08
52 Week High
$1.08
$4.55

Technical Indicators

Market Signals
Indicator
PASW
QNCX
Relative Strength Index (RSI) 41.59 49.53
Support Level $0.13 $0.10
Resistance Level $0.17 $1.50
Average True Range (ATR) 0.01 0.12
MACD -0.00 -0.06
Stochastic Oscillator 35.60 50.89

Price Performance

Historical Comparison
PASW
QNCX

About PASW Ping An Biomedical Co. Ltd. Ordinary Shares

Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Share on Social Networks: